Navigation Links
NIAID to convene HIV Vaccine Summit
Date:3/20/2008

What: On Tuesday, March 25, 2008, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will host an HIV Vaccine Summit in Bethesda, Md. as an important step in the ongoing process to examine the current direction of HIV vaccine research. Through interactive panel discussions, NIAID and the scientific community will explore

  • The optimal balance between vaccine discovery research and development studies designed to advance promising vaccine candidates into clinical trials

  • How to optimize and utilize non-human primate models to support vaccine research

  • How best to integrate clinical research with vaccine discovery efforts

Based on the panel discussions, NIAID is seeking specific recommendations on the types of research to foster and how to attract novel vaccine research ideas.

Media registration to attend the summit in-person has closed; however, media are invited to watch the summit during a live Webcast.

When: Tuesday, March 25, 2008 8:30 a.m. to 4:45 p.m. EST

Where: To view the online NIAID HIV Vaccine Webcast, go to: http://hivsummit.dgimeetingsupport.com. The View Webcast link will be live on March 25.

Contact: For more information, contact the NIAID Office of Communications at (301) 402-1663, niaidnews@niaid.nih.gov.


'/>"/>

Contact: NIAID Office of Communications
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Page: 1

Related medicine news :

1. NIAID scientists identify new cellular receptor for HIV
2. NIAID strengthens and expands Vaccine and Treatment Evaluation Units
3. NIAID funds $51M contract to create comprehensive model of immune responses
4. Accordia Global Health Foundation Convenes Inaugural Infectious Diseases Summit
5. Specialists in drug discovery and development convene
6. International and Domestic Leaders to Convene to Tackle Health Issues in the Arab American Community
7. Healing Our Land, Inc. and The Massachusetts Black Legislative Caucus Convene Prevention Is Power Community Forum on the Impact of HIV/AIDS on Communities of Color in Massachusetts
8. Global Experts Convene to Discuss Emotional Trauma Caused by Disasters
9. National Business Coalition on Health Convenes Multi-Stakeholder Leadership Group to Address Value Based Purchasing Trends
10. Thought Leaders in Morbid Obesity Treatment Convene at Upcoming Surgical Conference
11. California Affiliates of Susan G. Komen for the Cure Convene Celebrities, Breast Cancer Survivors and Activists to Challenge Elected Officials to Strengthen Breast Cancer Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... Lake City, Colo. (PRWEB) , ... April 21, 2017 , ... ... launch of the Flex House, the next project in the company’s esteemed VISION House ... to help homeowners use exactly the amount of resources they need to live affordably ...
(Date:4/21/2017)... Kong (PRWEB) , ... April 21, 2017 , ... The ... (U3DP), the first 3D printing facility among higher education institutions in Hong Kong to ... printing, in terms of the range and quantity of facilities in Hong Kong. ...
(Date:4/21/2017)... ... 2017 , ... Alive for Wellness is a group of clinical ... struggles. The Alive team uses advanced behavioral sciences treatment modalities to accomplish their ... mental health struggle is based on 10 modalities of treatment that include: ...
(Date:4/21/2017)... ... April 21, 2017 , ... Metrasens is honoured ... Trade, the UK’s most prestigious award for business success. The company has ... revenues and has grown by a total of 400% over the last six ...
(Date:4/21/2017)... ... 21, 2017 , ... BrightStar Care Salt Lake City, a home care agency ... (APCUT) and has appointed Rex Wheeler as its new Director of Business Development. “This ... and our ability to provide quality care to the community,” said Tammara Brown, owner ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Vanderbilt University Medical Center ... in Nashville , Tennesse have been ... Sphincter Stimulation for GERD (LESS GERD) trial. The EndoStim ... long-term reflux control by restoring normal function to the ... million people in the United States ...
(Date:4/19/2017)... 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... developing new treatments for cancer and other unmet ... previously announced underwritten public offering of 23,625,084 shares ... price of $2.00 per share, before deducting underwriting ... by Sorrento.  The net proceeds to Sorrento from ...
(Date:4/19/2017)...  New research provides evidence that an old drug may ... study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... disease, the oral drug levodopa has long been considered the ... the disease progresses, the effects of the medication can partially ...
Breaking Medicine Technology: